Gene · 7172
Papers3,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Critical Review of Hearing Rehabilitation in Pediatric Oncology: Specific Considerations and Barriers. | Curr Oncol | 2025 | 41002579 | PubTator, text mining | PubMed |
| Monoclonal Antibodies and Small-Molecule Therapies for Lichen Planus: Targeted Immunomodulation and Emerging Evidence. | Antibodies (Basel) | 2025 | 40981278 | PubTator, text mining | PubMed |
| Deciphering and targeting oncogenic pathways through integrated approaches and amino acid metabolism in hematologic malignancies. | Discov Oncol | 2025 | 40956459 | PubTator, text mining | PubMed |
| Anagen Effluvium as an Early Sign of Azathioprine Toxicity. | J Assoc Physicians India | 2025 | 40955898 | PubTator, text mining | PubMed |
| Unraveling the cellular mechanisms of thiopurine-induced pancreatitis in pediatric inflammatory bowel disease: Insights from induced pluripotent stem cell models. | Biomed Pharmacother | 2025 | 40946582 | PubTator, text mining | PubMed |
| Mechanistic insights into the cofactor binding dynamics and interaction between telmisartan and human thiopurine S-methyltransferase. | J Pharm Sci | 2025 | 40885334 | PubTator, text mining | PubMed |
| Examination of the TPMT and NUDT15*3 Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients with Inflammatory Bowel Disease. | Int J Mol Sci | 2025 | 40869181 | PubTator, text mining | PubMed |
| Construction of a prognostic risk-scoring model based on SASP-related genes in patients with skin cutaneous melanoma. | Discov Oncol | 2025 | 40864319 | PubTator, text mining | PubMed |
| NUDT15 Pharmacogenetics in Acute Lymphoblastic Leukemia: Synthesizing Progress for Personalized Thiopurine Therapy. | Med Sci (Basel) | 2025 | 40843735 | PubTator, text mining | PubMed |
| µCodes: A Universal Grid Platform for Microscale Mapping, Microscopy Navigation, and Multimodal Imaging. | Small | 2025 | 40838380 | PubTator, text mining | PubMed |
| Atopic Dermatitis Management: from Conventional Therapies to Biomarker-Driven Treatment Approaches. | Biomol Ther (Seoul) | 2025 | 40827120 | PubTator, text mining | PubMed |
| Genetic polymorphism associated with non-response to therapy in inflammatory bowel disease patients: a review. | Pharmacogenomics | 2025 | 40817688 | PubTator, text mining | PubMed |
| A GLIM-defined malnutrition-based model for predicting prognosis of cirrhotic patients with portal hypertension following TIPS procedure. | BMC Gastroenterol | 2025 | 40813957 | PubTator, text mining | PubMed |
| New insights into thiopurine toxicity: The contribution of rare XDH variants to myelotoxicity. | Biomed Pharmacother | 2025 | 40812208 | PubTator, text mining | PubMed |
Establishment of a novel predictive model for thiopurine-induced leucopenia based on the polymorphisms in the DNA-thioguanine nucleotide metabolite pathway in Chinese patients with inflammatory bowel disease. | Drug Metab Dispos | 2025 | 40774024 | PubTator, text mining | PubMed |
| Pharmacogenetics association with long-term clinical evolution in a kidney transplant patients cohort. | Curr Res Pharmacol Drug Discov | 2025 | 40761554 | PubTator, text mining | PubMed |
| The history and future of pharmacogenetics in Aotearoa/New Zealand. | J R Soc N Z | 2025 | 40756875 | PubTator, text mining | PubMed |
| Differential protein expressions of hepatic drug-metabolizing enzymes between White and Black Americans and the associated genetic polymorphisms. | Drug Metab Dispos | 2025 | 40753786 | PubTator, text mining | PubMed |
| Personalizing cancer therapy: the role of pharmacogenetics in overcoming drug resistance and toxicity. | Mol Biol Rep | 2025 | 40751817 | PubTator, text mining | PubMed |
| Consensus-Based Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): Basic Therapy, Topical Therapy, and Conventional Systemic Therapy. | Ann Dermatol | 2025 | 40736521 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7172/papers?page=5